Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.
Galanello R, Piga A, Forni GL, Bertrand Y, Foschini ML, Bordone E, Leoni G, Lavagetto A, Zappu A, Longo F, Maseruka H, Hewson N, Sechaud R, Belleli R, Alberti D.
Galanello R, et al. Among authors: sechaud r.
Haematologica. 2006 Oct;91(10):1343-51.
Haematologica. 2006.
PMID: 17018383
Clinical Trial.